Skip to content

Research on Using Small-for-size Grafts for Auxiliary Liver Transplantation in the Treatment of Portal Hypertension

Innovative Technology Research on Using Small-for-size Grafts for Auxiliary Liver Transplantation in the Treatment of Portal Hypertension

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07247877
Enrollment
396
Registered
2025-11-25
Start date
2014-01-01
Completion date
2029-12-31
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation

Brief summary

The objective of this observational study is to compare the safety profile of auxiliary liver transplantation using small-for-size grafts with that of conventional liver transplantation and to evaluate the efficacy of this technique. The primary research question it seeks to investigate is: "What are the differences in safety and efficacy between auxiliary liver transplantation utilizing small-for-size grafts and conventional liver transplantation for the treatment of portal hypertension?"

Interventions

None listed

Sponsors

Zhi-Jun Zhu
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \> 14 years. 2. Presence of decompensated portal hypertension. 3. Meeting the indications for liver transplantation surgery. 4. International Normalized Ratio (INR) \< 2.4. 5. Scheduled to undergo orthotopic auxiliary partial liver transplantation or conventional liver transplantation.

Exclusion criteria

1. Rare liver-related anatomical variations. 2. Presence of contraindications to liver transplantation combined with malignant tumors. 3. Grade III or higher portal vein thrombosis. 4. Severe systemic diseases unrelated to the etiology or complications of portal hypertension. 5. Special surgical procedures such as dual-graft liver transplantation. 6. Special graft sources including domino liver transplantation. 7. Liver re-transplantation.

Design outcomes

Primary

MeasureTime frame
overall survivalWithin one year after liver transplantation
ComplicationsWithin one year after liver transplantation
portal hypertension resolutionWithin one year after liver transplantation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026